1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Rare Kidney Disease Treatment Market
2.2. Global Rare Kidney Disease Treatment Market, By Indication, 2023 (US$ Million)
2.3. Global Rare Kidney Disease Treatment Market, By Product, 2023 (US$ Million)
2.4. Global Rare Kidney Disease Treatment Market, By Type of Molecule, 2023 (US$ Million)
2.5. Global Rare Kidney Disease Treatment Market, By Route of Administration, 2023 (US$ Million)
2.6. Global Rare Kidney Disease Treatment Market, By End User, 2023 (US$ Million)
2.7. Global Rare Kidney Disease Treatment Market, By Geography, 2023 (US$ Million)
2.8. Attractive Investment Proposition by Geography, 2023

3. Rare Kidney Disease Treatment Market: Competitive Analysis
3.1. Market Positioning of Key Rare Kidney Disease Treatment Market Vendors
3.2. Strategies Adopted by Rare Kidney Disease Treatment Market Vendors
3.3. Key Industry Strategies
4. Rare Kidney Disease Treatment Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Rare Kidney Disease Treatment Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Rare Kidney Disease Treatment Market: By Indication, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Market Value Forecast, by Indication, 2017–2031
5.3.1.1. Fabry Disease
5.3.1.2. Atypical Hemolytic Uremic Syndrome
5.3.1.3. Lupus Nephritis
5.3.1.4. Nephropathic Cystinosis
5.3.1.5. Others
5.3.2. Market Attractiveness Analysis, by Indication

6. Rare Kidney Disease Treatment Market: By Product, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Diagnosis
6.3.1.1. Blood Tests
6.3.1.2. Urine Tests
6.3.1.3. Imaging Tests
6.3.1.4. Others
6.3.2. Treatment
6.3.2.1. Drug Class
6.3.2.1.1. ACE Inhibitors
6.3.2.1.2. Angiotensin-II Receptor Blockers
6.3.2.1.3. Diuretics
6.3.2.1.4. Others

7. Rare Kidney Disease Treatment Market: By Type of Molecule, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2023 Versus 2032
7.3. Market Segmentation
7.3.1. Small Molecules
7.3.2. Biologics

8. Rare Kidney Disease Treatment Market: By Route of Administration, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Growth & Revenue Analysis: 2023 Versus 2032
8.3. Market Segmentation
8.3.1. Oral
8.3.2. Intravenous
8.3.3. Subcutaneous
8.3.4. Others

9. Rare Kidney Disease Treatment Market: By End User, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Growth & Revenue Analysis: 2023 Versus 2032
9.3. Market Segmentation
9.3.1. Hospitals
9.3.2. Diagnostic Laboratories
9.3.3. Others


10. North America Rare Kidney Disease Treatment Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Rare Kidney Disease Treatment Market: By Indication, 2022-2032, USD (Million)
10.3. Rare Kidney Disease Treatment Market: By Product, 2022-2032, USD (Million)
10.4. Rare Kidney Disease Treatment Market: By Type of Molecule, 2022-2032, USD (Million)
10.5. Rare Kidney Disease Treatment Market: By Route of Administration, 2022-2032, USD (Million)
10.6. Rare Kidney Disease Treatment Market: By End User, 2022-2032, USD (Million)
10.7.Rare Kidney Disease Treatment Market: By Region, 2022-2032, USD (Million)
10.7.1.North America
10.7.1.1. U.S.
10.7.1.1.1. Rare Kidney Disease Treatment Market: By Indication, 2022-2032, USD (Million)
10.7.1.1.2. Rare Kidney Disease Treatment Market: By Product, 2022-2032, USD (Million)
10.7.1.1.3. Rare Kidney Disease Treatment Market: By Type of Molecule, 2022-2032, USD (Million)
10.7.1.1.4. Rare Kidney Disease Treatment Market: By Route of Administration, 2022-2032, USD (Million)
10.7.1.1.5. Rare Kidney Disease Treatment Market: By End User, 2022-2032, USD (Million)
10.7.1.2. Canada
10.7.1.2.1. Rare Kidney Disease Treatment Market: By Indication, 2022-2032, USD (Million)
10.7.1.2.2. Rare Kidney Disease Treatment Market: By Product, 2022-2032, USD (Million)
10.7.1.2.3. Rare Kidney Disease Treatment Market: By Type of Molecule, 2022-2032, USD (Million)
10.7.1.2.4. Rare Kidney Disease Treatment Market: By Route of Administration, 2022-2032, USD (Million)
10.7.1.2.5. Rare Kidney Disease Treatment Market: By End User, 2022-2032, USD (Million)
10.7.1.3. Rest of North America
10.7.1.3.1. Rare Kidney Disease Treatment Market: By Indication, 2022-2032, USD (Million)
10.7.1.3.2. Rare Kidney Disease Treatment Market: By Product, 2022-2032, USD (Million)
10.7.1.3.3. Rare Kidney Disease Treatment Market: By Type of Molecule, 2022-2032, USD (Million)
10.7.1.3.4. Rare Kidney Disease Treatment Market: By Route of Administration, 2022-2032, USD (Million)
10.7.1.3.5. Rare Kidney Disease Treatment Market: By End User, 2022-2032, USD (Million)

11. UK and European Union Rare Kidney Disease Treatment Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Rare Kidney Disease Treatment Market: By Indication, 2022-2032, USD (Million)
11.3. Rare Kidney Disease Treatment Market: By Product, 2022-2032, USD (Million)
11.4. Rare Kidney Disease Treatment Market: By Type of Molecule, 2022-2032, USD (Million)
11.5. Rare Kidney Disease Treatment Market: By Route of Administration, 2022-2032, USD (Million)
11.6. Rare Kidney Disease Treatment Market: By End User, 2022-2032, USD (Million)
11.7.Rare Kidney Disease Treatment Market: By Region, 2022-2032, USD (Million)
11.7.1.UK and European Union
11.7.1.1. UK
11.7.1.1.1. Rare Kidney Disease Treatment Market: By Indication, 2022-2032, USD (Million)
11.7.1.1.2. Rare Kidney Disease Treatment Market: By Product, 2022-2032, USD (Million)
11.7.1.1.3. Rare Kidney Disease Treatment Market: By Type of Molecule, 2022-2032, USD (Million)
11.7.1.1.4. Rare Kidney Disease Treatment Market: By Route of Administration, 2022-2032, USD (Million)
11.7.1.1.5. Rare Kidney Disease Treatment Market: By End User, 2022-2032, USD (Million)
11.7.1.2. Germany
11.7.1.2.1. Rare Kidney Disease Treatment Market: By Indication, 2022-2032, USD (Million)
11.7.1.2.2. Rare Kidney Disease Treatment Market: By Product, 2022-2032, USD (Million)
11.7.1.2.3. Rare Kidney Disease Treatment Market: By Type of Molecule, 2022-2032, USD (Million)
11.7.1.2.4. Rare Kidney Disease Treatment Market: By Route of Administration, 2022-2032, USD (Million)
11.7.1.2.5. Rare Kidney Disease Treatment Market: By End User, 2022-2032, USD (Million)
11.7.1.3. Spain
11.7.1.3.1. Rare Kidney Disease Treatment Market: By Indication, 2022-2032, USD (Million)
11.7.1.3.2. Rare Kidney Disease Treatment Market: By Product, 2022-2032, USD (Million)
11.7.1.3.3. Rare Kidney Disease Treatment Market: By Type of Molecule, 2022-2032, USD (Million)
11.7.1.3.4. Rare Kidney Disease Treatment Market: By Route of Administration, 2022-2032, USD (Million)
11.7.1.3.5. Rare Kidney Disease Treatment Market: By End User, 2022-2032, USD (Million)
11.7.1.4. Italy
11.7.1.4.1. Rare Kidney Disease Treatment Market: By Indication, 2022-2032, USD (Million)
11.7.1.4.2. Rare Kidney Disease Treatment Market: By Product, 2022-2032, USD (Million)
11.7.1.4.3. Rare Kidney Disease Treatment Market: By Type of Molecule, 2022-2032, USD (Million)
11.7.1.4.4. Rare Kidney Disease Treatment Market: By Route of Administration, 2022-2032, USD (Million)
11.7.1.4.5. Rare Kidney Disease Treatment Market: By End User, 2022-2032, USD (Million)
11.7.1.5. France
11.7.1.5.1. Rare Kidney Disease Treatment Market: By Indication, 2022-2032, USD (Million)
11.7.1.5.2. Rare Kidney Disease Treatment Market: By Product, 2022-2032, USD (Million)
11.7.1.5.3. Rare Kidney Disease Treatment Market: By Type of Molecule, 2022-2032, USD (Million)
11.7.1.5.4. Rare Kidney Disease Treatment Market: By Route of Administration, 2022-2032, USD (Million)
11.7.1.5.5. Rare Kidney Disease Treatment Market: By End User, 2022-2032, USD (Million)
11.7.1.6. Rest of Europe
11.7.1.6.1. Rare Kidney Disease Treatment Market: By Indication, 2022-2032, USD (Million)
11.7.1.6.2. Rare Kidney Disease Treatment Market: By Product, 2022-2032, USD (Million)
11.7.1.6.3. Rare Kidney Disease Treatment Market: By Type of Molecule, 2022-2032, USD (Million)
11.7.1.6.4. Rare Kidney Disease Treatment Market: By Route of Administration, 2022-2032, USD (Million)
11.7.1.6.5. Rare Kidney Disease Treatment Market: By End User, 2022-2032, USD (Million)

12. Asia Pacific Rare Kidney Disease Treatment Market, 2022-2032, USD (Million)
12.1. Market Overview
12.2. Rare Kidney Disease Treatment Market: By Indication, 2022-2032, USD (Million)
12.3. Rare Kidney Disease Treatment Market: By Product, 2022-2032, USD (Million)
12.4. Rare Kidney Disease Treatment Market: By Type of Molecule, 2022-2032, USD (Million)
12.5. Rare Kidney Disease Treatment Market: By Route of Administration, 2022-2032, USD (Million)
12.6. Rare Kidney Disease Treatment Market: By End User, 2022-2032, USD (Million)
12.7.Rare Kidney Disease Treatment Market: By Region, 2022-2032, USD (Million)
12.7.1.Asia Pacific
12.7.1.1. China
12.7.1.1.1. Rare Kidney Disease Treatment Market: By Indication, 2022-2032, USD (Million)
12.7.1.1.2. Rare Kidney Disease Treatment Market: By Product, 2022-2032, USD (Million)
12.7.1.1.3. Rare Kidney Disease Treatment Market: By Type of Molecule, 2022-2032, USD (Million)
12.7.1.1.4. Rare Kidney Disease Treatment Market: By Route of Administration, 2022-2032, USD (Million)
12.7.1.1.5. Rare Kidney Disease Treatment Market: By End User, 2022-2032, USD (Million)
12.7.1.2. Japan
12.7.1.2.1. Rare Kidney Disease Treatment Market: By Indication, 2022-2032, USD (Million)
12.7.1.2.2. Rare Kidney Disease Treatment Market: By Product, 2022-2032, USD (Million)
12.7.1.2.3. Rare Kidney Disease Treatment Market: By Type of Molecule, 2022-2032, USD (Million)
12.7.1.2.4. Rare Kidney Disease Treatment Market: By Route of Administration, 2022-2032, USD (Million)
12.7.1.2.5. Rare Kidney Disease Treatment Market: By End User, 2022-2032, USD (Million)
12.7.1.3. India
12.7.1.3.1. Rare Kidney Disease Treatment Market: By Indication, 2022-2032, USD (Million)
12.7.1.3.2. Rare Kidney Disease Treatment Market: By Product, 2022-2032, USD (Million)
12.7.1.3.3. Rare Kidney Disease Treatment Market: By Type of Molecule, 2022-2032, USD (Million)
12.7.1.3.4. Rare Kidney Disease Treatment Market: By Route of Administration, 2022-2032, USD (Million)
12.7.1.3.5. Rare Kidney Disease Treatment Market: By End User, 2022-2032, USD (Million)
12.7.1.4. Australia
12.7.1.4.1. Rare Kidney Disease Treatment Market: By Indication, 2022-2032, USD (Million)
12.7.1.4.2. Rare Kidney Disease Treatment Market: By Product, 2022-2032, USD (Million)
12.7.1.4.3. Rare Kidney Disease Treatment Market: By Type of Molecule, 2022-2032, USD (Million)
12.7.1.4.4. Rare Kidney Disease Treatment Market: By Route of Administration, 2022-2032, USD (Million)
12.7.1.4.5. Rare Kidney Disease Treatment Market: By End User, 2022-2032, USD (Million)
12.7.1.5. South Korea
12.7.1.5.1. Rare Kidney Disease Treatment Market: By Indication, 2022-2032, USD (Million)
12.7.1.5.2. Rare Kidney Disease Treatment Market: By Product, 2022-2032, USD (Million)
12.7.1.5.3. Rare Kidney Disease Treatment Market: By Type of Molecule, 2022-2032, USD (Million)
12.7.1.5.4. Rare Kidney Disease Treatment Market: By Route of Administration, 2022-2032, USD (Million)
12.7.1.5.5. Rare Kidney Disease Treatment Market: By End User, 2022-2032, USD (Million)
12.7.1.6. Rest of Asia Pacific
12.7.1.6.1. Rare Kidney Disease Treatment Market: By Indication, 2022-2032, USD (Million)
12.7.1.6.2. Rare Kidney Disease Treatment Market: By Product, 2022-2032, USD (Million)
12.7.1.6.3. Rare Kidney Disease Treatment Market: By Type of Molecule, 2022-2032, USD (Million)
12.7.1.6.4. Rare Kidney Disease Treatment Market: By Route of Administration, 2022-2032, USD (Million)
12.7.1.6.5. Rare Kidney Disease Treatment Market: By End User, 2022-2032, USD (Million)

13. Latin America Rare Kidney Disease Treatment Market, 2022-2032, USD (Million)
13.1. Market Overview
13.2. Rare Kidney Disease Treatment Market: By Indication, 2022-2032, USD (Million)
13.3. Rare Kidney Disease Treatment Market: By Product, 2022-2032, USD (Million)
13.4. Rare Kidney Disease Treatment Market: By Type of Molecule, 2022-2032, USD (Million)
13.5. Rare Kidney Disease Treatment Market: By Route of Administration, 2022-2032, USD (Million)
13.6. Rare Kidney Disease Treatment Market: By End User, 2022-2032, USD (Million)
13.7.Rare Kidney Disease Treatment Market: By Region, 2022-2032, USD (Million)
13.7.1.Latin America
13.7.1.1. Brazil
13.7.1.1.1. Rare Kidney Disease Treatment Market: By Indication, 2022-2032, USD (Million)
13.7.1.1.2. Rare Kidney Disease Treatment Market: By Product, 2022-2032, USD (Million)
13.7.1.1.3. Rare Kidney Disease Treatment Market: By Type of Molecule, 2022-2032, USD (Million)
13.7.1.1.4. Rare Kidney Disease Treatment Market: By Route of Administration, 2022-2032, USD (Million)
13.7.1.1.5. Rare Kidney Disease Treatment Market: By End User, 2022-2032, USD (Million)
13.7.1.2. Mexico
13.7.1.2.1. Rare Kidney Disease Treatment Market: By Indication, 2022-2032, USD (Million)
13.7.1.2.2. Rare Kidney Disease Treatment Market: By Product, 2022-2032, USD (Million)
13.7.1.2.3. Rare Kidney Disease Treatment Market: By Type of Molecule, 2022-2032, USD (Million)
13.7.1.2.4. Rare Kidney Disease Treatment Market: By Route of Administration, 2022-2032, USD (Million)
13.7.1.2.5. Rare Kidney Disease Treatment Market: By End User, 2022-2032, USD (Million)
13.7.1.3. Rest of Latin America
13.7.1.3.1. Rare Kidney Disease Treatment Market: By Indication, 2022-2032, USD (Million)
13.7.1.3.2. Rare Kidney Disease Treatment Market: By Product, 2022-2032, USD (Million)
13.7.1.3.3. Rare Kidney Disease Treatment Market: By Type of Molecule, 2022-2032, USD (Million)
13.7.1.3.4. Rare Kidney Disease Treatment Market: By Route of Administration, 2022-2032, USD (Million)
13.7.1.3.5. Rare Kidney Disease Treatment Market: By End User, 2022-2032, USD (Million)

14. Middle East and Africa Rare Kidney Disease Treatment Market, 2022-2032, USD (Million)
14.1. Market Overview
14.2. Rare Kidney Disease Treatment Market: By Indication, 2022-2032, USD (Million)
14.3. Rare Kidney Disease Treatment Market: By Product, 2022-2032, USD (Million)
14.4. Rare Kidney Disease Treatment Market: By Type of Molecule, 2022-2032, USD (Million)
14.5. Rare Kidney Disease Treatment Market: By Route of Administration, 2022-2032, USD (Million)
14.6. Rare Kidney Disease Treatment Market: By End User, 2022-2032, USD (Million)
14.7.Rare Kidney Disease Treatment Market: By Region, 2022-2032, USD (Million)
14.7.1.Middle East and Africa
14.7.1.1. GCC
14.7.1.1.1. Rare Kidney Disease Treatment Market: By Indication, 2022-2032, USD (Million)
14.7.1.1.2. Rare Kidney Disease Treatment Market: By Product, 2022-2032, USD (Million)
14.7.1.1.3. Rare Kidney Disease Treatment Market: By Type of Molecule, 2022-2032, USD (Million)
14.7.1.1.4. Rare Kidney Disease Treatment Market: By Route of Administration, 2022-2032, USD (Million)
14.7.1.1.5. Rare Kidney Disease Treatment Market: By End User, 2022-2032, USD (Million)
14.7.1.2. Africa
14.7.1.2.1. Rare Kidney Disease Treatment Market: By Indication, 2022-2032, USD (Million)
14.7.1.2.2. Rare Kidney Disease Treatment Market: By Product, 2022-2032, USD (Million)
14.7.1.2.3. Rare Kidney Disease Treatment Market: By Type of Molecule, 2022-2032, USD (Million)
14.7.1.2.4. Rare Kidney Disease Treatment Market: By Route of Administration, 2022-2032, USD (Million)
14.7.1.2.5. Rare Kidney Disease Treatment Market: By End User, 2022-2032, USD (Million)
14.7.1.3. Rest of Middle East and Africa
14.7.1.3.1. Rare Kidney Disease Treatment Market: By Indication, 2022-2032, USD (Million)
14.7.1.3.2. Rare Kidney Disease Treatment Market: By Product, 2022-2032, USD (Million)
14.7.1.3.3. Rare Kidney Disease Treatment Market: By Type of Molecule, 2022-2032, USD (Million)
14.7.1.3.4. Rare Kidney Disease Treatment Market: By Route of Administration, 2022-2032, USD (Million)
14.7.1.3.5. Rare Kidney Disease Treatment Market: By End User, 2022-2032, USD (Million)

15. Company Profile
15.1. Calliditas Therapeutics AB
15.1.1. Company Overview
15.1.2. Financial Performance
15.1.3. Product Portfolio
15.1.4. Strategic Initiatives
15.2. GSK plc.
15.2.1. Company Overview
15.2.2. Financial Performance
15.2.3. Product Portfolio
15.2.4. Strategic Initiatives
15.3. Aurinia Pharmaceuticals, Inc.
15.3.1. Company Overview
15.3.2. Financial Performance
15.3.3. Product Portfolio
15.3.4. Strategic Initiatives
15.4. Amicus Therapeutics, Inc.
15.4.1. Company Overview
15.4.2. Financial Performance
15.4.3. Product Portfolio
15.4.4. Strategic Initiatives
15.5. Shire (Takeda Pharmaceutical Company Limited)
15.5.1. Company Overview
15.5.2. Financial Performance
15.5.3. Product Portfolio
15.5.4. Strategic Initiatives
15.6. Sanofi
15.6.1. Company Overview
15.6.2. Financial Performance
15.6.3. Product Portfolio
15.6.4. Strategic Initiatives
15.7. Advicenne
15.7.1. Company Overview
15.7.2. Financial Performance
15.7.3. Product Portfolio
15.7.4. Strategic Initiatives
15.8. Alexion Pharmaceuticals, Inc.
15.8.1. Company Overview
15.8.2. Financial Performance
15.8.3. Product Portfolio
15.8.4. Strategic Initiatives
15.9. Horizon Therapeutics plc
15.9.1. Company Overview
15.9.2. Financial Performance
15.9.3. Product Portfolio
15.9.4. Strategic Initiatives
15.10. Otsuka Pharmaceutical Co., Ltd.
15.10.1. Company Overview
15.10.2. Financial Performance
15.10.3. Product Portfolio
15.10.4. Strategic Initiatives
15.11. Reata Pharmaceuticals, Inc.
15.11.1. Company Overview
15.11.2. Financial Performance
15.11.3. Product Portfolio
15.11.4. Strategic Initiatives
15.12. Others
15.12.1. Company Overview
15.12.2. Financial Performance
15.12.3. Product Portfolio
15.12.4. Strategic Initiatives